Melatonin mitigates type 1 diabetes‐aggravated cerebral ischemia‐reperfusion injury through anti‐inflammatory and anti‐apoptotic effects
Brain and Behavior · 2023-09 · 13 (9)
DOI: 10.1002/brb3.3118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 16.06.2023. Verfasst von Qian Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Melatonin, Diabetes Mellitus, Type 1, Brain Ischemia, Reperfusion Injury. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Cerebral ischemia and diabetes mellitus (DM) are common diseases that often coexist and interact with each other. DM doubles the risk of ischemic stroke, and cerebral ischemia causes stress‐induced hyperglycemia. Most experimental stroke studies used healthy animals. Melatonin is neuroprotective against cerebral ischemia–reperfusion injury (CIRI) in non‐DM, normoglycemic animals through anti‐oxidant effect, anti‐inflammation, and anti‐apoptosis. Previous studies have also reported a negative correlation between hyperglycemia and urinary melatonin metabolite.
Objectives
The present study investigated the effects of type 1 DM (T1DM) on CIRI in rats and the role of melatonin against CIRI in T1DM animals.
Results
Our results revealed that T1DM aggravated CIRI, leading to greater weight loss, increased infarct volume, and worse neurological deficit. T1DM aggravated the post‐CIRI activation of nuclear factor kappa B (NF‐κB) pathway and increase in pro‐apoptotic markers. A single intraperitoneal injection of melatonin at 10 mg/kg given 30 min before ischemia onset attenuated CIRI in T1DM rats, resulting in less weight loss, decreased infarct volume, and milder neurological deficit when compared with the vehicle group. Melatonin treatment achieved anti‐inflammatory and anti‐apoptotic effects with reduced NF‐κB pathway activation, reduced mitochondrial cytochrome C release, decreased calpain‐mediated spectrin breakdown product (SBDP), and decreased caspase‐3‐mediated SBDP. The treatment also led to fewer iNOS+ cells, milder CD‐68+ macrophage/microglia infiltration, decreased TUNEL+ apoptotic cells, and better neuronal survival.
Conclusions
T1DM aggravates CIRI. Melatonin treatment is neuroprotective against CIRI in T1DM rats via anti‐inflammatory and anti‐apoptotic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
- Research Centre of Heart, Brain, Hormone & Healthy Aging, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
ORCID-Profile: Raymond Tak Fai Cheung
Zitieren
APA
Xu, Q., & Cheung, R. T. F. (2023). Melatonin mitigates type 1 diabetes‐aggravated cerebral ischemia‐reperfusion injury through anti‐inflammatory and anti‐apoptotic effects. Brain and Behavior, 13(9). https://doi.org/10.1002/brb3.3118
Vancouver
Xu Q, Cheung RTF. Melatonin mitigates type 1 diabetes‐aggravated cerebral ischemia‐reperfusion injury through anti‐inflammatory and anti‐apoptotic effects. Brain and Behavior. 2023;13(9). doi:10.1002/brb3.3118
BibTeX
@article{Xu2023,
author = {Xu, Qian and Cheung, Raymond Tak Fai},
title = {Melatonin mitigates type 1 diabetes‐aggravated cerebral ischemia‐reperfusion injury through anti‐inflammatory and anti‐apoptotic effects},
journal = {Brain and Behavior},
year = {2023},
volume = {13},
number = {9},
doi = {10.1002/brb3.3118}
}
EUVIMED